nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylpropanolamine—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.12	0.197	CbGbCtD
Phenylpropanolamine—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.113	0.185	CbGbCtD
Phenylpropanolamine—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.113	0.185	CbGbCtD
Phenylpropanolamine—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.102	0.167	CbGbCtD
Phenylpropanolamine—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0858	0.14	CbGbCtD
Phenylpropanolamine—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0776	0.127	CbGbCtD
Phenylpropanolamine—Nephrosis lower nephron—Efavirenz—acquired immunodeficiency syndrome	0.0276	0.0944	CcSEcCtD
Phenylpropanolamine—Renal tubular necrosis—Efavirenz—acquired immunodeficiency syndrome	0.00812	0.0277	CcSEcCtD
Phenylpropanolamine—Urinary hesitation—Zidovudine—acquired immunodeficiency syndrome	0.00805	0.0275	CcSEcCtD
Phenylpropanolamine—DRD1—nerve—acquired immunodeficiency syndrome	0.0077	0.0951	CbGeAlD
Phenylpropanolamine—SLC6A3—nerve—acquired immunodeficiency syndrome	0.00618	0.0764	CbGeAlD
Phenylpropanolamine—Urinary hesitation—Lamivudine—acquired immunodeficiency syndrome	0.00574	0.0196	CcSEcCtD
Phenylpropanolamine—Amphetamine—CARTPT—acquired immunodeficiency syndrome	0.00531	0.386	CrCbGaD
Phenylpropanolamine—Liver injury—Didanosine—acquired immunodeficiency syndrome	0.0052	0.0177	CcSEcCtD
Phenylpropanolamine—SLC6A2—nerve—acquired immunodeficiency syndrome	0.00499	0.0616	CbGeAlD
Phenylpropanolamine—L-Phenylalanine—TAT—acquired immunodeficiency syndrome	0.00485	0.353	CrCbGaD
Phenylpropanolamine—Liver injury—Nevirapine—acquired immunodeficiency syndrome	0.00467	0.016	CcSEcCtD
Phenylpropanolamine—MAOA—nerve—acquired immunodeficiency syndrome	0.0046	0.0568	CbGeAlD
Phenylpropanolamine—Hepatocellular injury—Didanosine—acquired immunodeficiency syndrome	0.00437	0.0149	CcSEcCtD
Phenylpropanolamine—Blood pressure increased—Nevirapine—acquired immunodeficiency syndrome	0.00393	0.0134	CcSEcCtD
Phenylpropanolamine—Hepatocellular injury—Nevirapine—acquired immunodeficiency syndrome	0.00393	0.0134	CcSEcCtD
Phenylpropanolamine—Hepatocellular injury—Stavudine—acquired immunodeficiency syndrome	0.0038	0.013	CcSEcCtD
Phenylpropanolamine—MAOA—blood plasma—acquired immunodeficiency syndrome	0.00348	0.0429	CbGeAlD
Phenylpropanolamine—Hepatocellular injury—Zidovudine—acquired immunodeficiency syndrome	0.0033	0.0113	CcSEcCtD
Phenylpropanolamine—Liver injury—Ritonavir—acquired immunodeficiency syndrome	0.00305	0.0104	CcSEcCtD
Phenylpropanolamine—Coordination abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00295	0.0101	CcSEcCtD
Phenylpropanolamine—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.0029	0.0358	CbGeAlD
Phenylpropanolamine—Coordination abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00283	0.00965	CcSEcCtD
Phenylpropanolamine—Pseudoephedrine—IL2—acquired immunodeficiency syndrome	0.00268	0.195	CrCbGaD
Phenylpropanolamine—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.00267	0.0329	CbGeAlD
Phenylpropanolamine—Coordination abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00261	0.00892	CcSEcCtD
Phenylpropanolamine—Hepatocellular injury—Ritonavir—acquired immunodeficiency syndrome	0.00257	0.00876	CcSEcCtD
Phenylpropanolamine—Coordination abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00252	0.00859	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Efavirenz—acquired immunodeficiency syndrome	0.00249	0.00851	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Delavirdine—acquired immunodeficiency syndrome	0.00238	0.00814	CcSEcCtD
Phenylpropanolamine—Irritability—Zidovudine—acquired immunodeficiency syndrome	0.00229	0.00781	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Ritonavir—acquired immunodeficiency syndrome	0.0022	0.00753	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Saquinavir—acquired immunodeficiency syndrome	0.00212	0.00724	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Efavirenz—acquired immunodeficiency syndrome	0.00206	0.00702	CcSEcCtD
Phenylpropanolamine—Ataxia—Efavirenz—acquired immunodeficiency syndrome	0.00198	0.00676	CcSEcCtD
Phenylpropanolamine—Tremor—Amprenavir—acquired immunodeficiency syndrome	0.00197	0.00671	CcSEcCtD
Phenylpropanolamine—MAOA—retina—acquired immunodeficiency syndrome	0.0019	0.0235	CbGeAlD
Phenylpropanolamine—Urinary retention—Ritonavir—acquired immunodeficiency syndrome	0.00177	0.00605	CcSEcCtD
Phenylpropanolamine—Ataxia—Ritonavir—acquired immunodeficiency syndrome	0.00175	0.00598	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Saquinavir—acquired immunodeficiency syndrome	0.00175	0.00598	CcSEcCtD
Phenylpropanolamine—DRD1—nervous system—acquired immunodeficiency syndrome	0.00173	0.0214	CbGeAlD
Phenylpropanolamine—Irritability—Saquinavir—acquired immunodeficiency syndrome	0.00171	0.00584	CcSEcCtD
Phenylpropanolamine—Ataxia—Saquinavir—acquired immunodeficiency syndrome	0.00169	0.00575	CcSEcCtD
Phenylpropanolamine—DRD1—central nervous system—acquired immunodeficiency syndrome	0.00167	0.0206	CbGeAlD
Phenylpropanolamine—SLC6A3—spinal cord—acquired immunodeficiency syndrome	0.00165	0.0204	CbGeAlD
Phenylpropanolamine—Drowsiness—Efavirenz—acquired immunodeficiency syndrome	0.00162	0.00554	CcSEcCtD
Phenylpropanolamine—Agitation—Nelfinavir—acquired immunodeficiency syndrome	0.00153	0.00522	CcSEcCtD
Phenylpropanolamine—SLC6A3—lung—acquired immunodeficiency syndrome	0.0015	0.0186	CbGeAlD
Phenylpropanolamine—Hallucination—Efavirenz—acquired immunodeficiency syndrome	0.00145	0.00495	CcSEcCtD
Phenylpropanolamine—Flushing—Indinavir—acquired immunodeficiency syndrome	0.00143	0.00488	CcSEcCtD
Phenylpropanolamine—ADRB1—lung—acquired immunodeficiency syndrome	0.00142	0.0176	CbGeAlD
Phenylpropanolamine—Tension—Zidovudine—acquired immunodeficiency syndrome	0.00142	0.00483	CcSEcCtD
Phenylpropanolamine—Anxiety—Nelfinavir—acquired immunodeficiency syndrome	0.00141	0.00482	CcSEcCtD
Phenylpropanolamine—Anxiety—Stavudine—acquired immunodeficiency syndrome	0.00141	0.00481	CcSEcCtD
Phenylpropanolamine—Nervousness—Zidovudine—acquired immunodeficiency syndrome	0.0014	0.00478	CcSEcCtD
Phenylpropanolamine—SLC6A3—nervous system—acquired immunodeficiency syndrome	0.00139	0.0172	CbGeAlD
Phenylpropanolamine—Anxiety—Abacavir—acquired immunodeficiency syndrome	0.00139	0.00474	CcSEcCtD
Phenylpropanolamine—Hallucination—Delavirdine—acquired immunodeficiency syndrome	0.00139	0.00473	CcSEcCtD
Phenylpropanolamine—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.00137	0.0169	CbGeAlD
Phenylpropanolamine—Tremor—Zidovudine—acquired immunodeficiency syndrome	0.00135	0.00461	CcSEcCtD
Phenylpropanolamine—Flushing—Efavirenz—acquired immunodeficiency syndrome	0.00135	0.00461	CcSEcCtD
Phenylpropanolamine—SLC6A3—central nervous system—acquired immunodeficiency syndrome	0.00134	0.0165	CbGeAlD
Phenylpropanolamine—MAOA—digestive system—acquired immunodeficiency syndrome	0.00134	0.0165	CbGeAlD
Phenylpropanolamine—DRD1—brain—acquired immunodeficiency syndrome	0.00132	0.0163	CbGeAlD
Phenylpropanolamine—ADRB1—nervous system—acquired immunodeficiency syndrome	0.00132	0.0163	CbGeAlD
Phenylpropanolamine—Tension—Indinavir—acquired immunodeficiency syndrome	0.00132	0.00449	CcSEcCtD
Phenylpropanolamine—Nervousness—Indinavir—acquired immunodeficiency syndrome	0.0013	0.00445	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Efavirenz—acquired immunodeficiency syndrome	0.0013	0.00444	CcSEcCtD
Phenylpropanolamine—ADRA1A—blood—acquired immunodeficiency syndrome	0.00129	0.0159	CbGeAlD
Phenylpropanolamine—Hallucination—Ritonavir—acquired immunodeficiency syndrome	0.00128	0.00438	CcSEcCtD
Phenylpropanolamine—MAOA—blood—acquired immunodeficiency syndrome	0.00127	0.0157	CbGeAlD
Phenylpropanolamine—ADRB1—central nervous system—acquired immunodeficiency syndrome	0.00127	0.0157	CbGeAlD
Phenylpropanolamine—Vision blurred—Indinavir—acquired immunodeficiency syndrome	0.00126	0.00432	CcSEcCtD
Phenylpropanolamine—Tremor—Indinavir—acquired immunodeficiency syndrome	0.00126	0.00429	CcSEcCtD
Phenylpropanolamine—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.00125	0.00426	CcSEcCtD
Phenylpropanolamine—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.00125	0.00426	CcSEcCtD
Phenylpropanolamine—Tension—Efavirenz—acquired immunodeficiency syndrome	0.00124	0.00425	CcSEcCtD
Phenylpropanolamine—Hallucination—Saquinavir—acquired immunodeficiency syndrome	0.00123	0.00421	CcSEcCtD
Phenylpropanolamine—Agitation—Indinavir—acquired immunodeficiency syndrome	0.00123	0.00421	CcSEcCtD
Phenylpropanolamine—Nervousness—Efavirenz—acquired immunodeficiency syndrome	0.00123	0.0042	CcSEcCtD
Phenylpropanolamine—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.00123	0.0042	CcSEcCtD
Phenylpropanolamine—MAOA—spinal cord—acquired immunodeficiency syndrome	0.00123	0.0152	CbGeAlD
Phenylpropanolamine—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.00123	0.00418	CcSEcCtD
Phenylpropanolamine—Anxiety—Zidovudine—acquired immunodeficiency syndrome	0.00122	0.00418	CcSEcCtD
Phenylpropanolamine—SLC6A2—lung—acquired immunodeficiency syndrome	0.00121	0.015	CbGeAlD
Phenylpropanolamine—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.00121	0.00414	CcSEcCtD
Phenylpropanolamine—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.00121	0.00412	CcSEcCtD
Phenylpropanolamine—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.00121	0.00412	CcSEcCtD
Phenylpropanolamine—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.0012	0.00411	CcSEcCtD
Phenylpropanolamine—Flushing—Ritonavir—acquired immunodeficiency syndrome	0.0012	0.00408	CcSEcCtD
Phenylpropanolamine—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.00119	0.00408	CcSEcCtD
Phenylpropanolamine—Tension—Delavirdine—acquired immunodeficiency syndrome	0.00119	0.00406	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.00119	0.00406	CcSEcCtD
Phenylpropanolamine—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.00119	0.00405	CcSEcCtD
Phenylpropanolamine—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.00119	0.00405	CcSEcCtD
Phenylpropanolamine—MAOA—vagina—acquired immunodeficiency syndrome	0.00118	0.0146	CbGeAlD
Phenylpropanolamine—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.00118	0.00402	CcSEcCtD
Phenylpropanolamine—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.00117	0.00398	CcSEcCtD
Phenylpropanolamine—Constipation—Stavudine—acquired immunodeficiency syndrome	0.00116	0.00395	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.00116	0.00395	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00115	0.00392	CcSEcCtD
Phenylpropanolamine—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.00114	0.0039	CcSEcCtD
Phenylpropanolamine—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.00114	0.00389	CcSEcCtD
Phenylpropanolamine—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.00114	0.00388	CcSEcCtD
Phenylpropanolamine—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.00112	0.0139	CbGeAlD
Phenylpropanolamine—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.00112	0.00382	CcSEcCtD
Phenylpropanolamine—MAOA—lung—acquired immunodeficiency syndrome	0.00112	0.0138	CbGeAlD
Phenylpropanolamine—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.00112	0.0138	CbGeAlD
Phenylpropanolamine—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.00111	0.00381	CcSEcCtD
Phenylpropanolamine—Tension—Ritonavir—acquired immunodeficiency syndrome	0.0011	0.00376	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.0011	0.00375	CcSEcCtD
Phenylpropanolamine—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.00109	0.00372	CcSEcCtD
Phenylpropanolamine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00109	0.00372	CcSEcCtD
Phenylpropanolamine—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.00108	0.0133	CbGeAlD
Phenylpropanolamine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00108	0.00368	CcSEcCtD
Phenylpropanolamine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00108	0.00368	CcSEcCtD
Phenylpropanolamine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.00108	0.00367	CcSEcCtD
Phenylpropanolamine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.00107	0.00364	CcSEcCtD
Phenylpropanolamine—SLC6A3—brain—acquired immunodeficiency syndrome	0.00106	0.0131	CbGeAlD
Phenylpropanolamine—CYP1A2—blood—acquired immunodeficiency syndrome	0.00106	0.0131	CbGeAlD
Phenylpropanolamine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.00106	0.00361	CcSEcCtD
Phenylpropanolamine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.00105	0.00359	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00105	0.00358	CcSEcCtD
Phenylpropanolamine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00105	0.00357	CcSEcCtD
Phenylpropanolamine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.00104	0.00356	CcSEcCtD
Phenylpropanolamine—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.00104	0.0129	CbGeAlD
Phenylpropanolamine—MAOA—nervous system—acquired immunodeficiency syndrome	0.00103	0.0128	CbGeAlD
Phenylpropanolamine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00103	0.00353	CcSEcCtD
Phenylpropanolamine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.00103	0.00352	CcSEcCtD
Phenylpropanolamine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.00103	0.00351	CcSEcCtD
Phenylpropanolamine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00102	0.00347	CcSEcCtD
Phenylpropanolamine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.00101	0.00345	CcSEcCtD
Phenylpropanolamine—Tension—Lamivudine—acquired immunodeficiency syndrome	0.00101	0.00345	CcSEcCtD
Phenylpropanolamine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00101	0.00345	CcSEcCtD
Phenylpropanolamine—ADRB1—brain—acquired immunodeficiency syndrome	0.00101	0.0125	CbGeAlD
Phenylpropanolamine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00101	0.00344	CcSEcCtD
Phenylpropanolamine—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.001	0.0124	CbGeAlD
Phenylpropanolamine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.001	0.00342	CcSEcCtD
Phenylpropanolamine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.001	0.00341	CcSEcCtD
Phenylpropanolamine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000998	0.00341	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000998	0.00341	CcSEcCtD
Phenylpropanolamine—MAOA—central nervous system—acquired immunodeficiency syndrome	0.000995	0.0123	CbGeAlD
Phenylpropanolamine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000992	0.00339	CcSEcCtD
Phenylpropanolamine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000992	0.00339	CcSEcCtD
Phenylpropanolamine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000991	0.00338	CcSEcCtD
Phenylpropanolamine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000984	0.00336	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000983	0.00336	CcSEcCtD
Phenylpropanolamine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000983	0.00336	CcSEcCtD
Phenylpropanolamine—ADRA2A—blood—acquired immunodeficiency syndrome	0.000977	0.0121	CbGeAlD
Phenylpropanolamine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000976	0.00333	CcSEcCtD
Phenylpropanolamine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000974	0.00332	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00097	0.00331	CcSEcCtD
Phenylpropanolamine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000966	0.0033	CcSEcCtD
Phenylpropanolamine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000965	0.00329	CcSEcCtD
Phenylpropanolamine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000952	0.00325	CcSEcCtD
Phenylpropanolamine—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000941	0.0116	CbGeAlD
Phenylpropanolamine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000937	0.0032	CcSEcCtD
Phenylpropanolamine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000936	0.00319	CcSEcCtD
Phenylpropanolamine—CYP1A2—lung—acquired immunodeficiency syndrome	0.000932	0.0115	CbGeAlD
Phenylpropanolamine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000927	0.00316	CcSEcCtD
Phenylpropanolamine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000925	0.00316	CcSEcCtD
Phenylpropanolamine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000923	0.00315	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000922	0.00315	CcSEcCtD
Phenylpropanolamine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00092	0.00314	CcSEcCtD
Phenylpropanolamine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000916	0.00313	CcSEcCtD
Phenylpropanolamine—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000906	0.0112	CbGeAlD
Phenylpropanolamine—Pseudoephedrine—TNF—acquired immunodeficiency syndrome	0.000904	0.0658	CrCbGaD
Phenylpropanolamine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000902	0.00308	CcSEcCtD
Phenylpropanolamine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000899	0.00307	CcSEcCtD
Phenylpropanolamine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000896	0.00306	CcSEcCtD
Phenylpropanolamine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000895	0.00306	CcSEcCtD
Phenylpropanolamine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000894	0.00305	CcSEcCtD
Phenylpropanolamine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000892	0.00305	CcSEcCtD
Phenylpropanolamine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000888	0.00303	CcSEcCtD
Phenylpropanolamine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000885	0.00302	CcSEcCtD
Phenylpropanolamine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000885	0.00302	CcSEcCtD
Phenylpropanolamine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000884	0.00302	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000883	0.00301	CcSEcCtD
Phenylpropanolamine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000883	0.00301	CcSEcCtD
Phenylpropanolamine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00088	0.003	CcSEcCtD
Phenylpropanolamine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000874	0.00298	CcSEcCtD
Phenylpropanolamine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000864	0.00295	CcSEcCtD
Phenylpropanolamine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000861	0.00294	CcSEcCtD
Phenylpropanolamine—SLC6A2—brain—acquired immunodeficiency syndrome	0.000858	0.0106	CbGeAlD
Phenylpropanolamine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000857	0.00292	CcSEcCtD
Phenylpropanolamine—ADRA2A—lung—acquired immunodeficiency syndrome	0.000857	0.0106	CbGeAlD
Phenylpropanolamine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000856	0.00292	CcSEcCtD
Phenylpropanolamine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000855	0.00292	CcSEcCtD
Phenylpropanolamine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000854	0.00292	CcSEcCtD
Phenylpropanolamine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000853	0.00291	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000853	0.00291	CcSEcCtD
Phenylpropanolamine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000849	0.0029	CcSEcCtD
Phenylpropanolamine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000848	0.00289	CcSEcCtD
Phenylpropanolamine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000847	0.00289	CcSEcCtD
Phenylpropanolamine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000842	0.00287	CcSEcCtD
Phenylpropanolamine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000841	0.00287	CcSEcCtD
Phenylpropanolamine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000833	0.00285	CcSEcCtD
Phenylpropanolamine—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.000829	0.0102	CbGeAlD
Phenylpropanolamine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000828	0.00283	CcSEcCtD
Phenylpropanolamine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000823	0.00281	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000816	0.00279	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000816	0.00278	CcSEcCtD
Phenylpropanolamine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000814	0.00278	CcSEcCtD
Phenylpropanolamine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000807	0.00276	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000807	0.00275	CcSEcCtD
Phenylpropanolamine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000805	0.00275	CcSEcCtD
Phenylpropanolamine—ADRA1A—brain—acquired immunodeficiency syndrome	0.000797	0.00985	CbGeAlD
Phenylpropanolamine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000797	0.00272	CcSEcCtD
Phenylpropanolamine—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000793	0.0098	CbGeAlD
Phenylpropanolamine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000793	0.00271	CcSEcCtD
Phenylpropanolamine—MAOA—brain—acquired immunodeficiency syndrome	0.00079	0.00976	CbGeAlD
Phenylpropanolamine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000786	0.00268	CcSEcCtD
Phenylpropanolamine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000785	0.00268	CcSEcCtD
Phenylpropanolamine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000783	0.00267	CcSEcCtD
Phenylpropanolamine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000783	0.00267	CcSEcCtD
Phenylpropanolamine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000779	0.00266	CcSEcCtD
Phenylpropanolamine—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000764	0.00943	CbGeAlD
Phenylpropanolamine—MAOA—lymph node—acquired immunodeficiency syndrome	0.000764	0.00943	CbGeAlD
Phenylpropanolamine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000762	0.0026	CcSEcCtD
Phenylpropanolamine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00076	0.0026	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000754	0.00258	CcSEcCtD
Phenylpropanolamine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000754	0.00257	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000749	0.00256	CcSEcCtD
Phenylpropanolamine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000749	0.00256	CcSEcCtD
Phenylpropanolamine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000747	0.00255	CcSEcCtD
Phenylpropanolamine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000742	0.00253	CcSEcCtD
Phenylpropanolamine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000742	0.00253	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000729	0.00249	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000726	0.00248	CcSEcCtD
Phenylpropanolamine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000724	0.00247	CcSEcCtD
Phenylpropanolamine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000719	0.00245	CcSEcCtD
Phenylpropanolamine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000699	0.00239	CcSEcCtD
Phenylpropanolamine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000696	0.00238	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000693	0.00236	CcSEcCtD
Phenylpropanolamine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000691	0.00236	CcSEcCtD
Phenylpropanolamine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00069	0.00235	CcSEcCtD
Phenylpropanolamine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000684	0.00234	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000675	0.0023	CcSEcCtD
Phenylpropanolamine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000658	0.00225	CcSEcCtD
Phenylpropanolamine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000655	0.00223	CcSEcCtD
Phenylpropanolamine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000652	0.00223	CcSEcCtD
Phenylpropanolamine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000652	0.00222	CcSEcCtD
Phenylpropanolamine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000651	0.00222	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000649	0.00222	CcSEcCtD
Phenylpropanolamine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000629	0.00215	CcSEcCtD
Phenylpropanolamine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000624	0.00213	CcSEcCtD
Phenylpropanolamine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000624	0.00213	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000619	0.00211	CcSEcCtD
Phenylpropanolamine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000615	0.0021	CcSEcCtD
Phenylpropanolamine—ADRA2A—brain—acquired immunodeficiency syndrome	0.000606	0.00749	CbGeAlD
Phenylpropanolamine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000605	0.00207	CcSEcCtD
Phenylpropanolamine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000588	0.00201	CcSEcCtD
Phenylpropanolamine—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000586	0.00724	CbGeAlD
Phenylpropanolamine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000583	0.00199	CcSEcCtD
Phenylpropanolamine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000582	0.00199	CcSEcCtD
Phenylpropanolamine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000577	0.00197	CcSEcCtD
Phenylpropanolamine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000577	0.00197	CcSEcCtD
Phenylpropanolamine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00056	0.00191	CcSEcCtD
Phenylpropanolamine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000556	0.0019	CcSEcCtD
Phenylpropanolamine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000556	0.0019	CcSEcCtD
Phenylpropanolamine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000555	0.00189	CcSEcCtD
Phenylpropanolamine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000544	0.00186	CcSEcCtD
Phenylpropanolamine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000534	0.00182	CcSEcCtD
Phenylpropanolamine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00053	0.00181	CcSEcCtD
Phenylpropanolamine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00053	0.00181	CcSEcCtD
Phenylpropanolamine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000523	0.00179	CcSEcCtD
Phenylpropanolamine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000499	0.0017	CcSEcCtD
